← FDA Drug Approvals (Drugs@FDA)

DALBAVANCIN HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: KINDOS · Approved 2025-11-26

Drug application

FDA Application #

ANDA218929

Application type

Abbreviated New Drug Application (Generic)

Brand name

DALBAVANCIN HYDROCHLORIDE

Generic name

DALBAVANCIN

Active ingredients

DALBAVANCIN HYDROCHLORIDE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

KINDOS

Manufacturer

Meitheal Pharmaceuticals Inc

First approval

2025-11-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown